symbol,statement_type,period_end,line_item,value
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-64497000000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-11808300000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,97200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,83390900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-86870500000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,End Cash Position,50433200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,24200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,47426100000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,2982900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,55920400000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-1757900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-4926300000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,83390900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,83390900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-11711100000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-11711100000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-11808300000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,97200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-75311000000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,9815600000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,150700000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,43073300000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,92589000000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-49515700000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,-42487400000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Sale Of Business,625600000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,-43113000000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-85914900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,955600000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-86870500000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure Reported,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,22373500000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-3801800000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-34012200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,-5595300000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-13001500000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-5762900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-5128900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-3823200000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-22226000000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,175600000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,24783400000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Depreciation,24783400000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-1434400000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,61600000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-357900000.0
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of Business,
AMBUJACEM.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,59223700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,11633600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-240500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,0.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,66609600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-44824600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,End Cash Position,30071000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,94000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,6135400000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,23841600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,56887700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-2340800000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-4964100000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,66609600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,66609600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-240500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-240500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-240500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,0.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-89504300000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,10036000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,260400000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-16251000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,534700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-16785700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,-23082200000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Sale Of Business,460500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,-23542700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-39611400000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,5213200000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-44824600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure Reported,
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,56458200000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-9155600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,1940900000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-7260200000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,9752400000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Payable,1029800000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-2282900000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,243500000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-8656000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,0.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,-1160600000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,16279000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Depreciation,16279000000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-576100000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,24700000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-1158100000.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
AMBUJACEM.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,58961000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Free Cash Flow,29750600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Repayment Of Debt,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Issuance Of Debt,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Issuance Of Capital Stock,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Capital Expenditure,-23341000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,End Cash Position,113584900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Other Cash Adjustment Outside Changein Cash,5800000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Beginning Cash Position,85715600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Changes In Cash,27863500000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Financing Cash Flow,-5157600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Other Financing Charges,35400000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Interest Paid Cff,-1318000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Cash Dividends Paid,-2021000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Common Stock Dividend Paid,-2021000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Common Stock Issuance,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Common Stock Issuance,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Issuance Payments Of Debt,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Short Term Debt Issuance,
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Short Term Debt Payments,
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Long Term Debt Issuance,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Long Term Debt Payments,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Long Term Debt Issuance,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Investing Cash Flow,-20070500000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Other Investing Changes,-200000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Interest Received Cfi,2783100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Dividends Received Cfi,43100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Investment Purchase And Sale,66900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Sale Of Investment,215900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Purchase Of Investment,-149000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Business Purchase And Sale,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Sale Of Business,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Purchase Of Business,
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net PPE Purchase And Sale,-22963400000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Sale Of PPE,377600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Purchase Of PPE,-23341000000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Capital Expenditure Reported,
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Operating Cash Flow,53091600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Taxes Refund Paid,-6476100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Working Capital,-3314100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Other Current Liabilities,3960700000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Other Current Assets,-1860400000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Payable,6503800000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Inventory,-11217100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Change In Receivables,-819900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Other Non Cash Items,-417600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Stock Based Compensation,80100000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Provisionand Write Offof Assets,111900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Depreciation And Amortization,11524900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Depreciation,11524900000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Gain Loss On Investment Securities,-122500000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Foreign Currency Exchange Gain Loss,33600000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Gain Loss On Sale Of PPE,252700000.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Gain Loss On Sale Of Business,0.0
AMBUJACEM.NS,cashflow,2021-12-31 00:00:00,Net Income From Continuing Operations,51644700000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Free Cash Flow,30986600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Repayment Of Debt,-58600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Issuance Of Debt,84700000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Issuance Of Capital Stock,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Capital Expenditure,-17336500000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,End Cash Position,85715600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Other Cash Adjustment Outside Changein Cash,8400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Beginning Cash Position,90118800000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Changes In Cash,-4411600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Financing Cash Flow,-39562200000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Other Financing Charges,-88400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Interest Paid Cff,-1130100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Cash Dividends Paid,-36646100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Common Stock Dividend Paid,-36646100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Common Stock Issuance,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Common Stock Issuance,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Issuance Payments Of Debt,26100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Short Term Debt Issuance,-58600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Short Term Debt Payments,-58600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Long Term Debt Issuance,84700000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Long Term Debt Payments,-58600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Long Term Debt Issuance,84700000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Investing Cash Flow,-13172500000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Other Investing Changes,-200000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Interest Received Cfi,3910400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Dividends Received Cfi,27900000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Investment Purchase And Sale,-79800000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Sale Of Investment,162207200000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Purchase Of Investment,-162287000000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Business Purchase And Sale,222400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Sale Of Business,222400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Purchase Of Business,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net PPE Purchase And Sale,-17253200000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Sale Of PPE,83300000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Purchase Of PPE,-17336500000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Capital Expenditure Reported,-17336500000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Operating Cash Flow,48323100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Taxes Refund Paid,-11701700000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Working Capital,7572300000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Other Current Liabilities,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Other Current Assets,
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Payable,922400000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Inventory,4204900000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Change In Receivables,2445000000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Other Non Cash Items,-966800000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Stock Based Compensation,36600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Provisionand Write Offof Assets,135300000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Depreciation And Amortization,11617800000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Depreciation,11617800000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Gain Loss On Investment Securities,-258200000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Foreign Currency Exchange Gain Loss,82900000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Gain Loss On Sale Of PPE,328600000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Gain Loss On Sale Of Business,-129100000.0
AMBUJACEM.NS,cashflow,2020-12-31 00:00:00,Net Income From Continuing Operations,39915900000.0
